Test Reporting
Karius Test Report
The Karius laboratory is CLIA-certified and CAP-accredited to perform high-complexity clinical laboratory testing. Over 85% of specimens received by 8:30 AM (PT) Monday through Saturday are reported the next day. Details on the test reporting process can be found here. To learn more about the new report layout, refer to the Understanding the Karius Test Report overview video
View Sample Karius Test Report
Karius Test Performance Data
Analytical Validation Performance
AMR Clinical Validation Performance Summary
PPA = Positive Percent Agreement
NPA = Negative Percent Agreement
Total Validation Yield = Calculated by sum of presence and absence calls for an AMR marker, divided by the sum of all microbes in that drug class category that could have those markers
aNo mecC, vanB or blaKPC were detected
bSCCmec and mecA combined
c54 of these detections had adjudicated blaCTX-M phenotype label and 52 had adjudicated blaKPC phenotype label
*Samples chosen may not represent pathogen abundance distribution in targeted patient population. **False positives come from samples where orthogonal confirmation was limited. Orthogonal confirmation methods included: blood culture, Vitek, Microscan Walkaway, Agar dilution, E test gradient strip, and other microbiology tools
Supporting validation data is available on file. For more information, please contact help@kariusdx.com
Access to Results
The Karius Test is available as a send-out test to hospitals. Karius Test results for existing customers are available via:
If you are a new customer and would like to place the first order for a Karius Test go here.
For any questions, please contact Customer Success, available via phone: (866) 452-7487 or email: help@kariusdx.com
To access validation data for v5.0 and prior, please contact Customer Success at (866) 452-7487 or send us an email at help@kariusdx.com.
